We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Sintered Porous Materials for Medical Applications


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Sintered Porous Materials for Medical Applications"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Porvair Filtration Group will be exhibiting at the Medica / CompaMed 2013 trade show in Düsseldorf.

On Stand F-08 in Hall 8a, Porvair will showcase regulatory approved BioVyon™ sintered porous plastic materials and its flagship product, Chromatrap®, based upon proprietary BioVyon™ technology and used by researchers to identify cancer biomarkers.

BioVyon™ porous materials are used for in vitro filtration, separation, venting and wicking applications in the medical, pharmaceutical and life science industries.

Through a combination of new material developments, including composites and surface modified structures, and working in partnership with OEM and end user customers, Porvair is able to achieve optimum design and regulatory approval.

Recent developments have included nasal spray filters, drug delivery filters and catheter vents. Manufactured in ISO-accredited cleanrooms, BioVyon™ materials exhibit very low particle shedding, low extractables and low bioburden, making them ideally suited to critical applications.

The Chromatrap® product, a novel chromatin immunoprecipitation (ChIP) assay, utilizes BioVyon™ material to which Protein A or Protein G has been chemically bound.

The Chromatrap® solid phase porous structure captures antibody-tagged DNA-protein complexes associated with cancers. This technology is paving the way in the quest for targeted cancer treatments and personalized medicines.

Advertisement